US Stock MarketDetailed Quotes
ICUI ICU Medical
- 174.180
- +3.760+2.21%
Close Sep 12 16:00 ET
4.25BMarket Cap-59650P/E (TTM)
177.710High165.000Low373.27KVolume172.150Open170.420Pre Close65.23MTurnover1.66%Turnover RatioLossP/E (Static)24.43MShares177.71052wk High2.09P/B3.92BFloat Cap78.28052wk Low--Dividend TTM22.50MShs Float321.700Historical High--Div YieldTTM7.46%Amplitude4.833Historical Low174.762Avg Price1Lot Size
ICU Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.58%596.46M | -0.35%566.66M | -0.92%2.26B | 1.70%587.86M | -7.45%553.31M | -2.08%549.31M | 4.70%568.65M | 73.21%2.28B | 69.74%578.01M | 77.90%597.86M |
| Operating revenue | 8.58%596.46M | -0.35%566.66M | -0.92%2.26B | 1.70%587.86M | -7.45%553.31M | -2.08%549.31M | 4.70%568.65M | 73.21%2.28B | 69.74%578.01M | 77.90%597.86M |
| Cost of revenue | 8.98%389.03M | 1.28%381.41M | -3.98%1.52B | 3.28%416.27M | -10.22%369.39M | -9.26%356.98M | 0.62%376.61M | 91.83%1.58B | 89.20%403.07M | 97.56%411.46M |
| Gross profit | 7.85%207.43M | -3.54%185.24M | 6.04%739.87M | -1.92%171.59M | -1.33%183.92M | 14.76%192.33M | 13.75%192.04M | 41.97%697.76M | 37.22%174.95M | 45.86%186.4M |
| Operating expense | 5.62%182.94M | 4.16%179.5M | -1.32%692.04M | 6.40%177.03M | -4.01%169.48M | -4.47%173.2M | -2.68%172.33M | 100.26%701.33M | 75.84%166.38M | 102.82%176.56M |
| Selling and administrative expenses | 5.74%159.55M | 3.33%157.66M | -0.27%606.69M | 8.17%154.62M | -3.16%148.61M | -4.95%150.9M | -0.42%152.57M | 101.05%608.35M | 75.47%142.93M | 105.11%153.45M |
| Research and development costs | 4.88%23.39M | 10.53%21.84M | -8.22%85.34M | -4.41%22.41M | -9.67%20.87M | -1.15%22.3M | -17.22%19.76M | 95.76%92.98M | 78.08%23.45M | 88.80%23.11M |
| Operating profit | 28.01%24.49M | -70.85%5.75M | 1,440.70%47.84M | -163.54%-5.44M | 46.77%14.44M | 239.46%19.13M | 338.71%19.71M | -102.53%-3.57M | -73.94%8.57M | -75.85%9.84M |
| Net non-operating interest income expense | 1.16%-23.84M | -5.58%-23.77M | -43.46%-95.22M | -21.60%-24.41M | -35.75%-24.18M | -56.22%-24.12M | -72.46%-22.52M | -3,448.89%-66.38M | -5,466.84%-20.07M | -3,447.37%-17.81M |
| Non-operating interest income | 63.96%2.81M | 51.06%2.65M | 69.48%7.51M | 785.97%2.3M | -47.77%1.75M | 105.52%1.71M | 197.28%1.75M | 55.99%4.43M | -145.27%-335K | 377.57%3.34M |
| Non-operating interest expense | 3.15%26.65M | 8.86%26.42M | 45.08%102.73M | 35.31%26.71M | 22.55%25.92M | 58.75%25.83M | 77.85%24.27M | 8,152.33%70.81M | 5,292.62%19.74M | 12,489.88%21.15M |
| Other net income (expense) | -12.92%-20.18M | -77.10%-18.74M | 30.47%-30.92M | 31.29%-6.83M | 132.75%4.37M | -245.27%-17.87M | 68.40%-10.58M | -121.47%-44.47M | -0.58%-9.94M | -297.20%-13.34M |
| Gain on sale of security | -382.83%-2.42M | -1,164.20%-1.72M | -2.39%-5.92M | -115.34%-2.57M | -45.27%-3.01M | 81.71%-501K | -27.35%162K | -468.34%-5.78M | -186.09%-1.19M | -130.22%-2.07M |
| Special income (charges) | -1.12%-16.79M | -53.96%-16.34M | 39.92%-25.16M | 34.38%-5.92M | 168.25%7.97M | -227.43%-16.6M | 68.99%-10.61M | -112.74%-41.88M | 5.97%-9.02M | -339.13%-11.67M |
| -Less：Restructuring and merger&acquisition | 2.61%16.8M | 59.02%16.4M | -36.41%25.01M | -23.30%6.74M | -181.62%-8.41M | 219.76%16.37M | -69.58%10.31M | 118.05%39.33M | -2.82%8.79M | 337.07%10.31M |
| -Gain on sale of property,plant,equipment | 105.24%12K | 121.89%65K | 94.01%-153K | 451.93%820K | 67.35%-446K | 64.39%-229K | 4.81%-297K | -54.69%-2.55M | 57.71%-233K | -355.33%-1.37M |
| Other non- operating income (expenses) | -26.55%-977K | -408.96%-682K | -94.81%166K | 507.69%1.66M | -244.83%-588K | -138.29%-772K | -126.59%-134K | 410.05%3.2M | 114.96%273K | 103.00%406K |
| Income before tax | 14.57%-19.53M | -174.61%-36.77M | 31.56%-78.3M | -71.03%-36.68M | 74.82%-5.37M | -35.65%-22.86M | 75.57%-13.39M | -192.88%-114.41M | -191.90%-21.45M | -156.18%-21.31M |
| Income tax | 114.49%1.87M | 175.57%2.7M | -21.24%-48.64M | -230.47%-19.53M | -55.62%-12.6M | -37.84%-12.93M | 78.62%-3.58M | -300.10%-40.12M | -273.24%-5.91M | -218.34%-8.1M |
| Net income | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M | -172.03%-74.29M | -177.97%-15.54M | -142.50%-13.21M |
| Net income continuous Operations | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M | -172.03%-74.29M | -177.97%-15.54M | -142.50%-13.21M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M | -172.03%-74.29M | -177.97%-15.54M | -142.50%-13.21M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -115.48%-21.41M | -302.27%-39.47M | 60.08%-29.66M | -10.37%-17.15M | 154.80%7.24M | -32.91%-9.93M | 74.23%-9.81M | -172.03%-74.29M | -177.97%-15.54M | -142.50%-13.21M |
| Basic earnings per share | -114.63%-0.88 | -297.56%-1.63 | 60.45%-1.23 | -9.23%-0.71 | 154.55%0.3 | -32.26%-0.41 | 74.53%-0.41 | -163.99%-3.11 | -169.15%-0.65 | -137.41%-0.55 |
| Diluted earnings per share | -114.63%-0.88 | -297.56%-1.63 | 60.45%-1.23 | -9.23%-0.71 | 154.55%0.3 | -32.26%-0.41 | 74.53%-0.41 | -165.61%-3.11 | -171.43%-0.65 | -138.46%-0.55 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data